Stocks
Scilex Holding CompanySCLXW
NASDAQHealthcareBiotechnology$0.03
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing non-opioid pain management products, including its lead drug ZTlido for postherpetic neuralgia. Investors track the company for its pipeline and the performance of its commercial-stage assets.
52W Range: $0.03-$0.04
Congressional Interest in Scilex Holding Company (SCLXW)
No congressional trades have been disclosed for Scilex Holding Company (SCLXW) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SCLXW?
No congressional trades found for this stock.